Reactive oxygen species (ROS) are a key determinant of cancer's metabolic phenotype
- PMID: 28940517
- DOI: 10.1002/ijc.31069
Reactive oxygen species (ROS) are a key determinant of cancer's metabolic phenotype
Abstract
Cancer cells exhibit a wide range of metabolic phenotypes, ranging from strict aerobic glycolysis to increased mitochondrial respiration. The cause and utility of this metabolic variation is poorly understood. Given that cancer cells experience heavy selection within their microenvironment, survival requires metabolic adaptation to both extracellular and intracellular conditions. Herein, we suggest that reactive oxygen species (ROS) are a key determinant of cancer's metabolic phenotype. Intracellular ROS levels can be modified by an assortment of critical parameters including oxygenation, glucose availability and growth factors. ROS act as integrators of environmental information as well as downstream effectors of signaling pathways. Maintaining ROS within a narrow range allows malignant cells to enhance growth and invasion while limiting their apoptotic susceptibility. Cancer cells actively modify their metabolism to optimize intracellular ROS levels and thereby improve survival. Furthermore, we highlight distinct metabolic phenotypes in response to oxidative stress and their tumorigenic drivers.
Keywords: ROS; Warburg; antioxidant; glycolysis; metabolism.
© 2017 UICC.
Similar articles
-
Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.Semin Oncol. 2014 Apr;41(2):195-216. doi: 10.1053/j.seminoncol.2014.03.002. Epub 2014 Mar 5. Semin Oncol. 2014. PMID: 24787293 Review.
-
Heterogeneity in Cancer Metabolism: New Concepts in an Old Field.Antioxid Redox Signal. 2017 Mar 20;26(9):462-485. doi: 10.1089/ars.2016.6750. Epub 2016 Jul 13. Antioxid Redox Signal. 2017. PMID: 27228792 Free PMC article. Review.
-
Proteomics analysis of tumor microenvironment: Implications of metabolic and oxidative stresses in tumorigenesis.Mass Spectrom Rev. 2013 Jul-Aug;32(4):267-311. doi: 10.1002/mas.21362. Epub 2012 Nov 19. Mass Spectrom Rev. 2013. PMID: 23165949 Review.
-
Warburg effect increases steady-state ROS condition in cancer cells through decreasing their antioxidant capacities (anticancer effects of 3-bromopyruvate through antagonizing Warburg effect).Med Hypotheses. 2013 Nov;81(5):866-70. doi: 10.1016/j.mehy.2013.08.024. Epub 2013 Sep 3. Med Hypotheses. 2013. PMID: 24071366
-
ROS and energy metabolism in cancer cells: alliance for fast growth.Arch Pharm Res. 2015 Mar;38(3):338-45. doi: 10.1007/s12272-015-0550-6. Epub 2015 Jan 20. Arch Pharm Res. 2015. PMID: 25599615 Review.
Cited by
-
Visualizing the effects of lactate dehydrogenase (LDH) inhibition and LDH-A genetic ablation in breast and lung cancer with hyperpolarized pyruvate NMR.NMR Biomed. 2021 Aug;34(8):e4560. doi: 10.1002/nbm.4560. Epub 2021 Jun 4. NMR Biomed. 2021. PMID: 34086382 Free PMC article.
-
Dysfunctional Glucose Metabolism in Alzheimer's Disease Onset and Potential Pharmacological Interventions.Int J Mol Sci. 2022 Aug 23;23(17):9540. doi: 10.3390/ijms23179540. Int J Mol Sci. 2022. PMID: 36076944 Free PMC article. Review.
-
Evaluation of HOCl-generating anticancer agents by an ultrasensitive dual-mode fluorescent probe.Chem Sci. 2019 Mar 4;10(13):3715-3722. doi: 10.1039/c9sc00180h. eCollection 2019 Apr 7. Chem Sci. 2019. PMID: 31015915 Free PMC article.
-
HIV-1 Reverse Transcriptase Expression in HPV16-Infected Epidermoid Carcinoma Cells Alters E6 Expression and Cellular Metabolism, and Induces a Hybrid Epithelial/Mesenchymal Cell Phenotype.Viruses. 2024 Jan 26;16(2):193. doi: 10.3390/v16020193. Viruses. 2024. PMID: 38399969 Free PMC article.
-
Anti-proliferation and apoptosis-inducing effects of dihydroartemisinin on SH-SY5Y cells and metabolomic analysis.Transl Pediatr. 2022 Aug;11(8):1346-1361. doi: 10.21037/tp-22-331. Transl Pediatr. 2022. PMID: 36072536 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources